Baseline C-reactive protein levels and prognosis in patients with infective endocarditis: A prospective cohort study. 2018

Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
Department of Cardiology, KMCT Medical College, Manassery, Mukkam, Calicut, India. Electronic address: stg222@gmail.com.

BACKGROUND Early diagnosis and risk-stratification among infective endocarditis (IE) patients are limited by poor microbiological yield and inadequate characterization of vegetations. A simple tool that can predict adverse outcomes in the early phase of management is required. OBJECTIVE To study the prognostic value of C-reactive protein (CRP) levels at admission and its role in predicting various clinical outcomes. METHODS In a prospective study of consecutive IE patients diagnosed by modified Duke's criteria, we measured the peak levels of CRP and erythrocyte sedimentation rate (ESR) in the first 3 days of admission and correlated it with in-hospital mortality, six-month mortality, embolic phenomena and the need for urgent surgery. Predefined laboratory-microbiological sampling protocols and antibiotic-initiation protocols were followed. Receiver-operating-characteristics curves were generated to identify a reliable cut-off for CRP in predicting various outcomes. RESULTS Out of 101 patients who were treated, 85 patients had 'definite' IE. Blood cultures were positive in 55% (n = 39); and Staphylococcus species was the most common organism. Major complications occurred in 74.1% (n = 63) and in-hospital mortality was 32.9% (n = 28). Mean ESR and CRP levels were 102 ± 31 mm/h and 51 ± 20 mg/l, respectively. In multivariable analysis, high CRP levels were independently predictive of mortality, major complications, embolic events and need for urgent surgery. A CRP >40 mg/l predicted adverse outcomes with a sensitivity of 73% and specificity of 99%. CONCLUSIONS The study shows that baseline CRP level in the first 3 days of admission is a strong predictor of short term adverse outcomes in IE patients, and a useful marker for early risk stratification.

UI MeSH Term Description Entries
D007194 India A country in southern Asia, bordering the Arabian Sea and the Bay of Bengal, between Burma and Pakistan. The capitol is New Delhi. Republic of India
D008297 Male Males
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D004696 Endocarditis Inflammation of the inner lining of the heart (ENDOCARDIUM), the continuous membrane lining the four chambers and HEART VALVES. It is often caused by microorganisms including bacteria, viruses, fungi, and rickettsiae. Left untreated, endocarditis can damage heart valves and become life-threatening. Infective Endocarditis,Endocarditides,Endocarditides, Infective,Endocarditis, Infective,Infective Endocarditides
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
January 2021, BioMed research international,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
May 2003, Chemotherapy,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
January 2018, Archives of Iranian medicine,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
January 1988, Journal of clinical pathology,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
August 2022, Cardiovascular diagnosis and therapy,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
January 2015, PloS one,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
January 2021, Frontiers in cardiovascular medicine,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
April 2006, European journal of cancer (Oxford, England : 1990),
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
June 2016, Medicine,
Sandeep Mohanan, and Rajesh Gopalan Nair, and Haridasan Vellani, and Sajeev C G, and Biju George, and Krishnan M N
September 2017, Oncotarget,
Copied contents to your clipboard!